Skip to content

F-220 Press-Fit Femoral Hip Stem System

by Implex Corp.

510(k) K935990

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SN Traditional NumberK935990 Date13 Jul 1994DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MEH
Device Class
Class II
Regulation
21 CFR Part 888.3353
Advisory Committee
Orthopedic
FDA Decision
SN

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The F-220 Press-Fit Femoral Hip Stem System is a femoral component of a semi-constrained hip prosthesis, designed to replace the femoral head and neck in total hip arthroplasty. It is intended for press-fit fixation within the femoral canal, providing stability through its geometric design without cement or porous coating.

This system is supplied as a reusable surgical implant, intended for use in orthopedic procedures under sterile conditions. It is regulated under FDA 510(k) clearance (K935990) and classified under product code MEH, with no specific MRI safety labeling indicated. Storage and handling must comply with standard orthopedic implant protocols.

Other devices from Implex Corp.

See all devices from Implex Corp. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of hip replacement procedures is the F-220 Press-Fit Femoral Hip Stem System intended for?

    The F-220 Press-Fit Femoral Hip Stem System is designed specifically for total hip arthroplasty, where it serves as the femoral component to replace the femoral head and neck. It is intended for press-fit fixation within the femoral canal, providing stability through its geometric design without the need for bone cement or porous coatings. This makes it suitable for primary hip replacements where a secure, non-cemented fixation is desired.

  • Is the F-220 Press-Fit Femoral Hip Stem System intended for single-use or can it be reused?

    The F-220 Press-Fit Femoral Hip Stem System is explicitly described as a reusable surgical implant. Since it is intended for use in orthopedic procedures under sterile conditions, it must be handled, cleaned, and sterilized according to standard orthopedic implant protocols to ensure safety and functionality for repeated use.

  • How should the F-220 Press-Fit Femoral Hip Stem System be stored, and what considerations should be taken into account?

    The F-220 Press-Fit Femoral Hip Stem System must be stored and handled in compliance with standard orthopedic implant protocols, which typically include maintaining sterility, protecting from contamination, and adhering to manufacturer guidelines for shelf life and environmental conditions. Since it is reusable, proper cleaning, sterilization, and storage procedures are critical to prevent damage or degradation before reuse in subsequent procedures.

  • What regulatory pathway was followed for the FDA clearance of the F-220 Press-Fit Femoral Hip Stem System?

    The F-220 Press-Fit Femoral Hip Stem System received FDA clearance through a 510(k) submission, specifically under the traditional review pathway. It was classified under product code MEH (Orthopedic Prosthesis, Hip, Femoral Component) and was determined to be substantially equivalent for some indications by the Orthopedic (OR) Advisory Committee. The clearance was granted on July 13, 1994, following a review process initiated on December 14, 1993.